MedPath

海南盈达润泽药业有限公司

Ownership
-
Established
2022-12-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Calcium Lactate,Calcium Gluconate and Calcium Hydrogen Phosphate Chewable Tablets

Product Name
三合钙咀嚼片
Approval Number
国药准字H34022192
Approval Date
Jul 19, 2024
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H34022906
Approval Date
Jul 18, 2024
NMPA

Glutamine Powders

Product Name
谷氨酰胺散
Approval Number
国药准字H20080324
Approval Date
Dec 20, 2022
NMPA

Levofloxacin Hydrochloride Capsules

Product Name
盐酸左氧氟沙星胶囊
Approval Number
国药准字H20066206
Approval Date
Apr 1, 2021
NMPA

Metoprolol Tartrate Sustained-release Tablets

Product Name
酒石酸美托洛尔缓释片
Approval Number
国药准字H20066315
Approval Date
Feb 26, 2021
NMPA

复方益肝灵胶囊

Approval Number
国药准字Z20060425
Approval Date
Dec 24, 2020
NMPA

Vitamin D2 and Calcium Hydrogen Phospate Tablets

Product Name
维D2磷酸氢钙片
Approval Number
国药准字H34022286
Approval Date
Dec 16, 2020
NMPA

健脾安神胶囊

Approval Number
国药准字Z20050522
Approval Date
Jul 27, 2020
NMPA

维血宁合剂

Approval Number
国药准字Z34020804
Approval Date
Jul 1, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H34022883
Approval Date
Jun 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.